StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$27.40−2.96 (-9.75%)

Close on Nov 17, 2026Market cap $2.64BP/E –Yield –

IDEAYA Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

IDEAYA Biosciences's price to book ratio was 2.6× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 1.2× to 5.0×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.6×−0.1
2025Dec 31, 20252.8×+0.9
2024Dec 31, 20241.9×−2.2
2023Dec 29, 20234.1×+1.7
2022Dec 30, 20222.4×−0.5
2021Dec 31, 20212.9×+0.8
2020Dec 31, 20202.1×+0.7
2019Dec 31, 20191.4×–

More IDEAYA Biosciences figures

See a number that looks wrong?